Roche buys U.S. gene sequencing tech company Stratos Genomics

Business News

[ad_1]

FILE PHOTO: General view of the Roche building in Welwyn Garden City, following the outbreak of the coronavirus disease (COVID-19), Welwyn Garden City, Britain, May 14, 2020. REUTERS/Paul Childs

ZURICH (Reuters) – Pharmaceutical group Roche (ROG.S) has acquired U.S.-based Stratos Genomics to further develop DNA-based sequencing for diagnostic use, it said on Friday.

“The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion,” the Swiss drug maker said in a statement. “The Roche nanopore sequencer, once developed, will utilise a novel approach that combines electronic and biological components to sequence DNA for fast, flexible and cost-effective clinical diagnostic testing.”

You Might Like

Financial details of the agreement were not disclosed.

Reporting by Brenna Hughes Neghaiwi; editing by Thomas Seythal

[ad_2]

Read the Original Article Here

Articles You May Like

Disney Drops Lawsuits Against DeSantis-Backed Tourism District
MSNBC Hosts Spike The Football After NBC’s Firing Of Ronna McDaniel
‘Slap in the face’: Dad of Parkland school shooting victim blasts Kamala’s ‘photo op’ visit at massacre site to ‘push an agenda’
What Our Baby Bust Says About Modern America
Senator Amy Klobuchar Gets ROASTED on Twitter/X for Obnoxious Comment About Passage of Massive Spending Package

Leave a Reply

Your email address will not be published. Required fields are marked *